Results 11 to 20 of about 4,608 (197)

Clinical Outcomes of Individualized Botulinum Neurotoxin Type A Injection Techniques in Patients with Essential Blepharospasm [PDF]

Korean Journal of Ophthalmology, 2015
To assess the clinical outcomes following botulinum neurotoxin type A (BoNT-A) treatment with an individualized injection technique based on the types of spasms and to compare the results of the individualized injection technique with those of the conventional injection technique in the same patients.From November 2011 to July 2013, 77 BoNT-A ...
Sung, Youngje, Nam, Sang Min, Lew, Helen
openaire   +3 more sources

Treatment with Botulinum Neurotoxin Improves Activities of Daily Living and Quality of Life in Patients with Upper Limb Tremor

Tremor and Other Hyperkinetic Movements, 2019
Background: Botulinum neurotoxin’s degree of effectiveness on upper limb tremor is subject to debate; although this treatment reduces the tremor’s amplitude, a clear functional benefit has not been demonstrated.
Alexandre Kreisler, Benoîte Bouchain, Luc Defebvre, Pierre Krystkowiak   +3 more
doaj   +5 more sources

Histopathological changes of the buccal mucosa and skin after botulinum neurotoxin intramuscular injection in rats (immunohistochemical study)

BMC Oral Health
Background A surplus of clinical studies focused mainly on the clinical impacts of botulinum neurotoxin type A disregarding the histopathological changes stemming from its injection.
Gihan S. Hassan, Basant H. Abouzaid, Reda G. Saleh   +2 more
doaj   +2 more sources

Intraprostatic botulinum neurotoxin type a injection for benign prostatic hyperplasia: preliminary results with a newly purified neurotoxin.

Acta medica Okayama, 2012
Several studies have demonstrated the efficacy of intraprostatic injection of botulinum neurotoxin type A (BoNT/A) against symptomatic benign prostatic hyperplasia (BPH). The most commonly used BoNT/A product, Botox(®), forms large complexes and composed of neurotoxin (NTX) as well as non-toxic components.
Yokoyama, Teruhiko, Yamamoto, Yumiko, Suzuki, Tomonori, Oguma, Keiji, Nagai, Atsushi   +4 more
openaire   +4 more sources

Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children—update and practice recommendations [PDF]

Frontiers in Neurology, 2023
Sialorrhea is defined as a chronic excessive flow of saliva from the mouth, often with adverse consequences for health and quality of life of patients.
Wolfgang H. Jost, Tobias Bäumer, Andrea Bevot, Ulrich Birkmann, Carsten Buhmann, Maria Grosheva, Orlando Guntinas-Lichius, Rainer Laskawi, Sebastian Paus, Christina Pflug, A. Sebastian Schroeder, Björn Spittau, Armin Steffen, Bernd Wilken, Martin Winterholler, Steffen Berweck   +15 more
doaj   +3 more sources

Dysphagia After Cosmetic Submandibular Gland Botulinum Neurotoxin Type A Injection: A Case Report [PDF]

Healthcare
Background: Cosmetic injection of botulinum neurotoxin type A (BoNT/A) into the submandibular glands is increasingly performed to enhance jawline contour. Although generally considered safe, unintended diffusion of the toxin can impair pharyngeal musculature and lead to dysphagia.
Seoyon Yang, You Gyoung Yi
openaire   +3 more sources

Botulinum Neurotoxin A Injections in Spasmodic Entropion: A Clinical Retrospective Cohort Study

Toxins
While surgical procedure has been considered as the golden standard treatment for spasmodic entropion, Botulinum Neurotoxin A can be indicated in the treatment of spasmodic entropion for fragile elderly patients.
Brigitte Girard, Fabienne Carré, Simon Begnaud   +2 more
doaj   +2 more sources

Neutralizing antibodies to botulinum neurotoxin type A in aesthetic medicine: five case reports

Clinical, Cosmetic and Investigational Dermatology, 2013
Sebastian Torres,1 Mark Hamilton,2 Elena Sanches,4 Polina Starovatova,3 Elena Gubanova,3 Tatiana Reshetnikova51Di Stefano Velona Clinic, Catania, Italy; 2Hamilton Face Clinic, Dublin, Ireland; 3Preventive Medicine Clinic "Vallex M", Moscow ...
Torres S, Hamilton M, Sanches E, Starovatova P, Gubanova E, Reshetnikova T   +5 more
doaj   +1 more source

Transcranial Direct Current Stimulation Combined with Botulinum Neurotoxin Type A Injections for Treatment of Upper Limb Intention Tremor in Multiple Sclerosis: A Case Report

Case Reports in Neurology, 2021
Upper limb intention tremor is a common cause of disability in multiple sclerosis (MS). Transcranial direct current stimulation (tDCS) is an emerging form of brain stimulation used to improve sensorimotor impairments in many neurological disorders. Here,
Salvatore Facciorusso, Stefania Spina, Luigi Santoro, Nicoletta Cinone, Alessio Baricich, Chiara Ciritella, Pietro Fiore, Andrea Santamato   +7 more
doaj   +2 more sources

Single Application of A2 NTX, a Botulinum Toxin A2 Subunit, Prevents Chronic Pain Over Long Periods in Both Diabetic and Spinal Cord Injury–Induced Neuropathic Pain Models

Journal of Pharmacological Sciences, 2012
Botulinum toxin type A is a unique candidate for inhibition of pain transmission. In the present study we attempted to see the beneficial actions of A2 neurotoxin (NTX), an active subunit of botulinum toxin type A.
Lin Ma, Jun Nagai, Yuki Sekino, Yoshitaka Goto, Shinji Nakahira, Hiroshi Ueda   +5 more
doaj   +2 more sources